Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Leukemia

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2012.63PMID 22460735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

  2011cited by this paper
• Chronic lymphocytic leukemia

  2011cited by this paper
• Preliminary Results From A Phase I Dose Escalation Study to Determine the Maximum Tolerated Dose of Plerixafor In Combination with Rituximab In Patients with Relapsed Chronic Lymphocytic Leukemia

  2010cited by this paper
• CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

  2009cited by this paper
• High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.

  2009cited by this paper
• Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.

  2009cited by this paper
• miR-34b/miR-34c: a regulator of TCL1 expression in 11q− chronic lymphocytic leukaemia?

  2009cited by this paper
• AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.

  2009cited by this paper
• The microenvironment in mature B-cell malignancies: a target for new treatment strategies.

  2009cited by this paper
• Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells.

  2008cited by this paper
• Bcl-2-family proteins and hematologic malignancies: history and future prospects.

  2008cited by this paper
• Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL

  2008cited by this paper
• The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance

  2008cited by this paper
• CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.

  2008cited by this paper
• Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis.

  2007cited by this paper
• TCL1 in B-cell Tumors Retains its Normal B-cell Pattern of Regulation and is a Marker of Differentiation Stage

  2007cited by this paper
• High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.

  2007cited by this paper
• Magnitude of Stromal Hemangiogenesis Correlates with Histologic Subtype of Non–Hodgkin's Lymphoma

  2006cited by this paper
• TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state

  2006cited by this paper
• Fibroblasts in cancer

  2006cited by this paper
• Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.

  2006cited by this paper
• Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia.

  2005cited by this paper
• In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

  2005cited by this paper
• Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.

  2005cited by this paper
• CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.

  2005cited by this paper
• Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells.

  2003cited by this paper
• JunB inhibits proliferation and transformation in B-lymphoid cells.

  2003cited by this paper
• AP-1: a double-edged sword in tumorigenesis

  2003cited by this paper
• Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

  2002cited by this paper
• AP-1 as a regulator of cell life and death

  2002cited by this paper
• Chemokine Receptors and Stromal Cells in the Homing and Homeostasis of Chronic Lymphocytic Leukemia B Cells

  2002cited by this paper
• Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy.

  2001cited by this paper
• The protooncogene TCL1 is an Akt kinase coactivator.

  2000cited by this paper
• Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

  2000cited by this paper
• Fates of human B-cell precursors.

  2000cited by this paper
• Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.

  2000cited by this paper
• Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.

  2000cited by this paper
• Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

  1999cited by this paper
• Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

  1998cited by this paper
• Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells

  1998cited by this paper
• Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro

  1996cited by this paper
• Positive and negative selection events during B lymphopoiesis.

  1995cited by this paper
• Apoptosis and Macrophage‐Mediated Cell Deletion in the Regulation of B Lymphopoiesis in Mouse Bone Marrow

  1994cited by this paper
• Identification of the TCL1 gene involved in T-cell malignancies.

  1994cited by this paper
• Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines.

  1992cited by this paper
• Regulation of hemopoiesis by bone marrow stromal cells and their products.

  1990cited by this paper
• Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow

  1990cited by this paper
• Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

  1988cited by this paper
• Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non‐hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis

  1984cited by this paper
• Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data.

  1984cited by this paper
• Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas.

  1980cited by this paper

• Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model

  2022cites this paper
• The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.

  2022cites this paper
• T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

  2022cites this paper
• The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A

  2021cites this paper
• MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia

  2021cites this paper
• Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells–leukemia cells

  2020cites this paper
• The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies

  2020cites this paper
• Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application

  2019cites this paper
• Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL

  2019cites this paper
• Chapter 2 The CLL Cell Microenvironment

  2019cites this paper
• Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury

  2019cites this paper
• Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients

  2018cites this paper
• T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1

  2018cites this paper
• Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications

  2018influential citation
• Nucleotide excision repair as a targetable vulnerability in leukemia

  2017cites this paper
• Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia

  2017cites this paper
• The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells12

  2017cites this paper
• Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.

  2016cites this paper
• Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions

  2015cites this paper
• Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia

  2015cites this paper
• The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL

  2015cites this paper
• Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

  2015cites this paper
• Investigation into the efficacy of the anti-CD20 monoclonal antibody ofatumumab in chronic lymphocytic leukaemia

  2015cites this paper
• Etudes des altérations fonctionnelles de la signalisation dépendante du récepteur à l’antigène dans les cellules B de la Leucémie Lymphoïde Chronique

  2015cites this paper
• Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.

  2014cites this paper
• AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1.

  2014cites this paper
• Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies.

  2014cites this paper
• miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review).

  2014cites this paper
• The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.

  2014cites this paper
• Therapeutics , Targets , and Chemical Biology Aurano fi n Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia

  2014cites this paper
• Molecular Pathology of Chronic Lymphocytic Leukemia and Relevance to Novel Therapies

  2014cites this paper
• Isocitrate dehydrogenase 1 ( IDH 1 ) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH 1 wild type

  2013cites this paper
• Chronic lymphocytic leukaemia – the role of the microenvironment pathogenesis and therapy

  2013cites this paper
• CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.

  2013cites this paper
• Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling.

  2013cites this paper
• TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q

  2013cites this paper
• The CLL cell microenvironment.

  2013cites this paper
• PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis

  2013cites this paper
• Prognostic Role of MicroRNA-181a/b in Hematological Malignancies: A Meta-Analysis

  2013cites this paper
• Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type

  2013cites this paper
• The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies.

  2012cites this paper